Product NDC: | 28595-300 |
Proprietary Name: | Brohist D |
Non Proprietary Name: | Brompheniramine Maleate and Phenylephrine Hydrochloride |
Active Ingredient(s): | 4; 10 mg/1; mg/1 & nbsp; Brompheniramine Maleate and Phenylephrine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 28595-300 |
Labeler Name: | Allegis Pharmaceuticals, LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20120910 |
Package NDC: | 28595-300-60 |
Package Description: | 60 TABLET, COATED in 1 BOTTLE (28595-300-60) |
NDC Code | 28595-300-60 |
Proprietary Name | Brohist D |
Package Description | 60 TABLET, COATED in 1 BOTTLE (28595-300-60) |
Product NDC | 28595-300 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Brompheniramine Maleate and Phenylephrine Hydrochloride |
Dosage Form Name | TABLET, COATED |
Route Name | ORAL |
Start Marketing Date | 20120910 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Allegis Pharmaceuticals, LLC |
Substance Name | BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 4; 10 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |